Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
75,607,738
-
Total 13F shares
-
49,154,429
-
Share change
-
+3,997,176
-
Total reported value
-
$2,774,763,179
-
Put/Call ratio
-
93%
-
Price per share
-
$56.44
-
Number of holders
-
127
-
Value change
-
+$222,688,221
-
Number of buys
-
61
-
Number of sells
-
60
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q1 2022
As of 31 Mar 2022,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,154,429 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., BOXER CAPITAL, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DRIEHAUS CAPITAL MANAGEMENT LLC, and BANK OF AMERICA CORP /DE/.
This page lists
128
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.